Korean J Med.  2013 May;84(5):659-669.

Current Management of Pulmonary Thromboembolism

Affiliations
  • 1Department of Respiratory Medicine, Thrombosis Clinic, Soonchunhyang University Seoul Hospital, Seoul, Korea. kyklung@schmc.ac.kr

Abstract

The incidence of venous thromboembolism (VTE) including deep vein thrombosis (DVT) and pulmonary embolism (PE) is increasing in Korea. In addition, awareness of VTE according to the incidence is improving, but how long VTE should be treated and how effective VTE patients should be managed with warfarin is not well defined. Recently, various new oral anticoagulants (NOACs) were introduced in clinical practice. The duration of anticoagulation, quality control of warfarin, and practical use of NOACs in VTE would be reviewed with evidences.

Keyword

Venous thromboembolism; Anticoagulants; Quality control; Duration of anticoagulation

MeSH Terms

Anticoagulants
Humans
Incidence
Korea
Pulmonary Embolism
Quality Control
Venous Thromboembolism
Venous Thrombosis
Warfarin
Anticoagulants
Warfarin
Full Text Links
  • KJM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr